Simplex Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,118
| Closed | – | – | 11106 |
|
|
2021
Q1 | $0 | Buy |
13,118
+7,826
| +148% | +$195K | ﹤0.01% | 10541 |
|
|
2020
Q4 | $90K | Buy |
5,292
+5,108
| +2,776% | +$64K | ﹤0.01% | 5555 |
|
|
2020
Q3 | $0 | Buy |
+184
| New | +$935 | ﹤0.01% | 8881 |
|
|
2020
Q1 | – | Sell |
-23,259
| Closed | -$98.7K | – | 8587 |
|
|
2019
Q4 | $106K | Buy |
23,259
+18,928
| +437% | +$75K | ﹤0.01% | 4461 |
|
|
2019
Q3 | $16K | Buy |
4,331
+3,723
| +612% | +$20.4K | ﹤0.01% | 5980 |
|
|
2019
Q2 | $3K | Sell |
608
-6,280
| -91% | -$60K | ﹤0.01% | 6695 |
|
|
2019
Q1 | $92K | Sell |
6,888
-231
| -3% | -$2.63K | ﹤0.01% | 4432 |
|
|
2018
Q4 | $66K | Sell |
7,119
-5,264
| -43% | -$62.6K | ﹤0.01% | 4268 |
|
|
2018
Q3 | $172K | Sell |
12,383
-7,102
| -36% | -$106K | ﹤0.01% | 3834 |
|
|
2018
Q2 | $308K | Buy |
19,485
+3,931
| +25% | +$68.6K | ﹤0.01% | 2986 |
|
|
2018
Q1 | $267K | Buy |
+15,554
| New | +$303K | 0.01% | 1063 |
|
|
2017
Q1 | – | Sell |
-290
| Closed | -$12.8K | – | 7067 |
|
|
2016
Q4 | $14K | Buy |
290
+130
| +81% | +$6.83K | ﹤0.01% | 3429 |
|
|
2016
Q3 | $8K | Sell |
160
-500
| -76% | -$23.9K | ﹤0.01% | 3874 |
|
|
2016
Q2 | $27K | Buy |
+660
| New | +$28.7K | ﹤0.01% | 2644 |
|
|
2016
Q1 | – | Sell |
-2,133
| Closed | -$73.3K | – | 6545 |
|
|
2015
Q4 | $88K | Sell |
2,133
-300
| -12% | -$10.1K | 0.01% | 1462 |
|
|
2015
Q3 | $37K | Buy |
+2,433
| New | +$52.3K | ﹤0.01% | 2244 |
|
Simplex Trading's FPRX Position: Q2 2021 in Review
Simplex Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 13,118 shares.
Simplex Trading first reported a position in FPRX in Q3 2015 and held it in 16 quarters. The position peaked at $308K in Q2 2018. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Simplex Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Simplex Trading sold 13,118 Five Prime Therapeutics, Inc. shares in Q2 2021.
- Simplex Trading first reported a position in Five Prime Therapeutics, Inc. in Q3 2015 and held it in 16 quarters.
- Simplex Trading's Five Prime Therapeutics, Inc. position peaked at $308K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.